<http://schema.org/description>
"Mixed late-stage trial data backs Rigel&amp;#39;s rheumatoid arthritis drug up against the wall."^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.fool.com/investing/general/2013/04/05/growing-aches-and-pains-sink-rigel-pharmaceuticals.aspx>